美西南航空航班連續第三日大規模延誤或取消
《美聯社》報道,美國西南航空(LUV.US)連續第三日出現大量航班取消或延誤,昨日(11日)再取消逾350個航班,相等預定航班一成。另有最少1,400個航班延誤,佔原定航班四成。
報道指,代表9,000名機師的西南航空機師協會,上週五(8日)入稟聯邦法院挑戰所有員工須接種疫苗規定,其後西南航空航班出現大規模取消或延誤。工會指西南航空須就強制接種疫苗磋商,因機師對疫苗的反應或引發病假或不適合飛行。工會亦指摘航空公司運作問題導致過去數天的混亂。
西南航空營運總監Mike Van de Ven承認,公司尚未聘請足夠員工,尤其是機師。公司因員工短缺已縮減秋季航班計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.